There has been little improvement in the natural history of HCC because of late diagnosis in many cases and suboptimal systemic treatment of the disease in the advanced stage.2,3 Our findings here highlight SAG-UPS as a promising candidate for both early diagnosis and development of therapeutics. The gene discussed is SAG; the disease is hepatocellular carcinoma.